Climate-tech startups often prepare hardware, field installation, long-term validation, certification, and a data platform at the same time. That makes simple formulas such as “survive as long as possible on government grants, then raise investment” or “use loans first to avoid equity dilution” sound attractive. But the price of money is not determined by interest or ownership percentage alone. Restrictions on use, repayment timing, reporting duties, and who bears failure risk all matter.

An optimal capital structure is not simply the one that collects the cheapest money. It assigns technology uncertainty, market uncertainty, delivery working capital, and organizational expansion to different sources, connecting them so that evidence created by one source improves the terms of the next. What a company can actually obtain depends on calls, evaluation, collateral and guarantee terms, and investment review; this is a decision framework, not a funding guarantee.

The misconception that policy finance is “free capital” and investment is “expensive capital”

Government R&D is highly useful for technology development, but it is not unrestricted cash to cover revenue losses. Agreed research goals and periods, eligible costs, institutional contributions, and performance and settlement duties apply. Using R&D funds outside the prescribed purpose can lead to clawbacks or sanctions. Investment, in contrast, may have no repayment date but carries equity, voting and information rights and expectations of future exit. Neither is money without conditions.

Guarantees and loans can reduce dilution, but they require repayment capacity and cash flow. They may fit inventory for sensor mass production or working capital for confirmed deliveries; using short-term debt to fund long-term algorithm research with uncertain timing and outcome increases maturity risk. Repeatedly using investment capital to cover installation losses is not a solution either: it increases growth funding without validating a structure in which losses grow with every installation.

Match the nature of funding to four kinds of risk

The first is technology risk . Whether sensors perform in barn conditions, emissions can be reconstructed by combining ventilation volume and concentration, and missing data can be controlled belongs to R&D and testing. Work that leaves knowledge and can be assessed against predefined research outcomes even when it fails fits government R&D well.

The second is validation risk . Devices must be installed on farms and observed across seasons, while maintenance, feeding compliance, baselines, and verification costs are checked. Validation sits between research and sales. Mix public validation programs, customer co-funding, strategic partner funds, and equity, while putting the next purchase condition in the contract so free validation does not continue forever.

The third is commercialization risk . Even if a product works, who buys it at what price and who pays installation, calibration, and cloud costs are separate questions. Investment capital, with fewer use restrictions and capacity to absorb losses, fits testing repeatable pricing, paid conversion, payback periods, and retention. Investors allocate capital not only to research success but also to the speed of market learning and the scaling model.

The fourth is working-capital risk . If a purchase order exists and the gap between delivery and collection is clear, guaranteed loans or receivables-based finance may be considered. Using that money for uncertain product exploration makes repayment dates collide with the learning period. Conversely, funding all production costs for confirmed sales with equity can cause unnecessary dilution.

Field scenario: from before bringing in 20 devices to scaling to 100 farms

Assume a livestock-methane platform first tests its sensors and calculation pipeline on two farms. The goal is not to show the “world’s best platform,” but to quantify calibration, data coverage, installation time, field failure rate, and baseline reproducibility. Government R&D can fund specific technical questions and test plans, while founders or early investment fund product-scope adjustments and customer interviews.

The next 20 paid validations require equipment production and installation staff. If customers bear part of the cost, evidence of willingness to pay and the purchasing process emerges. If a subsidy covers all customer contribution, installation counts may rise without validating market pricing; record the pre-subsidy price and customer-paid price separately. After repeated installations, installation cost per farm, monthly maintenance cost, data validity rate, and support time should be visible.

Scaling to 100 farms is an operating-system problem, not a research project. Supply chain, inventory, installation partners, remote updates, incident response, and contract renewals require funding. It is better to separate accounts: investment for proactively scaling the organization and platform; policy finance for equipment and working capital within each product’s permitted use and repayment source; and follow-on R&D for distinct technology risks such as new barn types or overseas standards.

Plan the funding sequence around an evidence schedule, not a “runway”

A plan that only watches monthly cash balances is insufficient. Set evidence milestones—technical performance → reference-farm validation → paid conversion → repeat installation → renewal—then work backward from the cash needed before each stage ends and the time required for the next raise. Calls, guarantee reviews, and investment rounds have different schedules and can fail, so do not count unconfirmed funding as cash.

The 2026 integrated technology-development announcement from the Ministry of SMEs and Startups sets targets, support periods, and conditions for each program. The same year’s SME Technology Innovation Development Program includes detailed tracks such as export-oriented support and notes preference for carbon-neutral strategic technologies. This does not mean every climate-tech company is automatically selected. Choose calls that fit the company’s work and technology maturity, and do not distort the business plan to fit funding.

The Korea Technology Finance Corporation’s guarantee-linked investment evaluates eligible technology-innovative companies among guarantee customers and connects them to direct investment. It shows that policy finance and equity investment are not institutionally separate worlds. The Korea Fund of Funds also recycles recovery proceeds to supply venture-investment capital. Investment by policy-backed funds still undergoes independent review by the manager, so do not confuse being in a policy sector with investment being confirmed.

Operating rule: separate ledgers and failure scenarios by funding source

For each funding source, put permitted use, spending period, institutional contribution, settlement and reporting, repayment and dilution, prerequisites, obligations on failure on one page. Do not allocate the same labor or equipment cost to multiple projects, and distinguish research prototypes from sale inventory in accounting and asset management. The integrated cash plan seen by the representative must connect to project-level evidence ledgers.

Make decisions using base, delay, and failure scenarios. Check how long payroll and essential operations can continue if R&D selection is delayed by three months, an investment round fails, or customer acceptance is delayed. Match debt repayment to conservative confirmed cash flow, not hoped-for sales. Before investment, do not present unconfirmed grants as confirmed matching funds; before applying for a grant, check the use plan and overlap with already-invested funds.

Implementation checklist

  • Have technology development, field validation, commercialization, and working-capital risks and budgets been separated?

  • Have the use limits, self-funding, settlement, repayment, and equity terms of each source been compared in one table?

  • Are funds under selection or review distinguished from confirmed cash?

  • Do government-project outputs connect to the Evidence Package customers require?

  • Does every free validation have a paid-conversion condition and end criterion?

  • Are production costs for confirmed orders funded separately from uncertain research costs?

  • Are installation cost, monthly maintenance, and verification costs included in the funding plan?

  • Have you calculated the period needed to reach the next evidence milestone rather than simply 18 months after investment?

  • Is there a cash scenario for funding delay or failure and delayed customer collection?

  • Are project funds and company funds separated in ledgers, approval rights, and evidence?

Conclusion

A climate-tech startup’s capital structure is not optimized by a fixed percentage of policy finance and a fixed percentage of investment. Separate the roles of funding that absorbs technical failure, funding that co-funds field validation, funding that accelerates market learning, and funding that connects confirmed deliveries.

A good combination lets R&D create performance evidence, validation funding create operating evidence, investment create a repeatable business model, and guarantee- or loan-based policy finance stabilize the cash cycle of confirmed orders within each product’s requirements and permitted use. What matters more than the amount raised is whether each source clearly creates the next stage’s evidence and defines the company’s obligations if it fails.

Sources